Clinical Trials

178 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT07291063 2025-12-18

Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

50 enrolled

Cholangiocarcinoma

NCT07243288 2025-11-21

RADIOPAN

Active not recruiting

400 enrolled

Pancreatic Neoplasms

NCT06893380 2025-09-15

GENTIS

61 enrolled

Biliary Tract Neoplasms

NCT03724994 2025-08-29

CHAMP

201 enrolled

Pancreatic Neoplasms

NCT06975917 2025-05-16

TOG-SAFRADJU

Active not recruiting

600 enrolled

Biliary Tract Neoplasms

NCT06883136 2025-03-19

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

Enrolling by invitation

43 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06809374 2025-02-05

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

100 enrolled

Pancreatic Cancer Resectable

NCT04544969 2025-01-28

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

50 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Neoplastic Cells, Circulating

NCT04423731 2024-11-20

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Active not recruiting

251 enrolled

Locally Advanced Pancreatic Adenocarcinoma

NCT02555813 2020-10-19

Treatment of Pancreatic Cancer With Abraxane

317 enrolled

Pancreatic Neoplasms

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Unknown

4,724 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04133155 2020-03-13

Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer

103 enrolled

Pancreatic Neoplasms

NCT04258163 2020-02-10

Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy

760 enrolled

Breast

Breast Neoplasms

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Unknown

300 enrolled

Breast

Breast Cancer Organoids

NCT03668418 2018-09-12

xenoZ

Unknown

120 enrolled

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT01782690 2018-07-23

An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

338 enrolled 18 charts

Pancreatic Neoplasms

NCT01251653 2016-05-30

A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel

94 enrolled 33 charts

Tumor-Agnostic

Neoplasms

NCT00235235 2015-12-09

A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

Terminated

80 enrolled

Breast

Breast Neoplasms

NCT00419042 2013-10-01

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00795678 2013-08-02

Chemotherapeutic Agents in Brain/Breast

10 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT00301301 2010-01-12

A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)